Skip to Main Content

Author Details

David N Watkins
Research Institute in Oncology and Hematology
1991
122
51
PMIDPaper TitleJournal TitlePublished Year
37098540MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.J Exp Clin Cancer Res2023
37845394Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.Oncogene2023
34675406Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.Oncogene2022
35732702SILAC kinase screen identifies potential MASTL substrates.Sci Rep2022
34973373Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice.Biochim Biophys Acta Mol Basis Dis2022
33983115A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma.Elife2021
32568216Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.J Clin Invest2020
33235907p53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis.Mol Cell Oncol2020
30348992Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.Oncogene2019
31683879A Sexually Dimorphic Role for STAT3 in Sonic Hedgehog Medulloblastoma.Cancers (Basel)2019
30898150Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.Breast Cancer Res2019
30833304ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.EMBO Mol Med2019
30936196Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.Cold Spring Harb Mol Case Stud2019
29277856A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.Invest New Drugs2018
30045976Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.Sci Transl Med2018
30042390Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.Nat Commun2018
30464171Hedgehog stimulates hair follicle neogenesis by creating inductive dermis during murine skin wound healing.Nat Commun2018
29743597MASTL overexpression promotes chromosome instability and metastasis in breast cancer.Oncogene2018
29367758The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.Oncogene2018
28074012Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.Sci Signal2017
28257959The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.J Thorac Oncol2017
28187190Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.PLoS One2017
29176597In vivo evidence that RBM5 is a tumour suppressor in the lung.Sci Rep2017
28650469A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.Oncogene2017
28646020MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.Cancer Res2017
28820907Positive regulatory interactions between YAP and Hedgehog signalling in skin homeostasis and BCC development in mouse skin in vivo.PLoS One2017
28581526The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer.Oncogene2017
27893707Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Oncogene2017
26920892Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors.Clin Cancer Res2016
27931239MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Breast Cancer Res2016
27669108Immunotherapy for malignant mesothelioma: reality check.Expert Rev Anticancer Ther2016
27780599Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.Pathology2016
27417119Mechanisms regulating phosphatase specificity and the removal of individual phosphorylation sites during mitotic exit.Bioessays2016
27551510Mitochondrial DNA plasticity is an essential inducer of tumorigenesis.Cell Death Discov2016
26740067The mouse endometrium contains epithelial, endothelial and leucocyte populations expressing the stem cell marker telomerase reverse transcriptase.Mol Hum Reprod2016
26872783PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells.J Cell Sci2016
25125202Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.Eur J Nucl Med Mol Imaging2015
26270676Hedgehog Signaling in the Maintenance of Cancer Stem Cells.Cancers (Basel)2015
26425664Dataset from the global phosphoproteomic mapping of early mitotic exit in human cells.Data Brief2015
26371045The Evolution of Therapies in Non-Small Cell Lung Cancer.Cancers (Basel)2015
26055452Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation Motifs.Mol Cell Proteomics2015
25605927BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs.Proc Natl Acad Sci U S A2015
25544756Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis.Oncotarget2015
23978713The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.J Hepatol2014
25191746Genomic characterisation of small cell lung cancer patient-derived xenografts generated from endobronchial ultrasound-guided transbronchial needle aspiration specimens.PLoS One2014
25152208Reply to: "The many faces of Hedgehog signalling in the liver: recent progress reveals striking cellular diversity and the importance of microenvironments".J Hepatol2014
25083987Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.J Clin Invest2014
24762066Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.Breast Cancer Res2014
24887064Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.PLoS One2014
24907066The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.Lung2014
  • 1 - 50 of 122

Recommended Authors

Stanford University
Career Start Year 2012
Number of shared co-authors 1
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 0
University of Naples
Career Start Year 2010
Number of shared co-authors 6
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 6
University of Toronto
Career Start Year 2005
Number of shared co-authors 2
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year 2003
Number of shared co-authors 2
Duke University
Career Start Year 2003
Number of shared co-authors 5
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 3
David Geffen School of Medicine at University of California at Los Angeles
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Maastricht University Medical Centre+
Career Start Year 1997
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 4
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 8
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 6
David Geffen School of Medicine at university of california los angeles
Career Start Year 1987
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 5
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 1
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 6
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 17
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1967
Number of shared co-authors 9

Collaborators

Co-authored papers 22
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 15
Monash University
Co-authored papers 9
Co-authored papers 8
St Vincent's Hospital
Co-authored papers 6
Queen's University
Co-authored papers 6
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 5
Garvan Institute of Medical Research
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Montefiore Medical Center
Co-authored papers 4
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Peter MacCallum Cancer Centre
Co-authored papers 3
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
St. Vincent's Hospital, University of Melbourne
Co-authored papers 3
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 3
Northern Hospital
Co-authored papers 3
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 2
Weill-Cornell School of Medicine
Co-authored papers 2
Royal Melbourne Hospital
Co-authored papers 2
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Co-authored papers 2
Department of Pediatrics Stanford University Stanford California USA.
Co-authored papers 2
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 2
Austin Hospital
Co-authored papers 2
Co-authored papers 2
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Churchill Hospital
Co-authored papers 2